Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study

ConclusionICI-treated patients may exhibit a higher risk of ATEs, especially after 1  year of treatment.

Source: Cancer Medicine - August 16, 2023 Category: Cancer & Oncology Authors: Jie Zhu, Yue Chen, Yuanlong Zhang, Wei Wang, Yujue Wang, Zhuo Lu, Yulin Zhang, Haike Lei, Dairong Li, Bo Long, Haixia Liu Tags: RESEARCH ARTICLE Source Type: research